Replies to post #14711 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Will have zero effect on lil AP and better read of the matter here:

www.huffpost.com/entry/fda-aduhelm-alzheimer-drug-price-should-worry_n_60c84f9ee4b02df18f7fed84

Insiders game that taxpayers will be left with paying the annual $100 Billion to administer (medicare) the drug treatment to millions of Alzheimer patients in the USA.

Bottom line is Biogen shareholders win - which likely includes FDA personnel who helped to trump up the drug for approval.

Peace,

M$